AstraZeneca Pharma India Limited Statistics
Want to see IN:ASTRAZEN full AI Analyst Report?
AstraZeneca Pharma India Limited (ASTRAZEN) Stock Statistics & Valuation Metrics
Total Valuation
AstraZeneca Pharma India Limited has a market cap or net worth of INR 154.16B. The enterprise value is INR 149.93B.
- Market Cap
- INR 154.16B
- Enterprise Value
- INR 149.93B
Share Statistics
AstraZeneca Pharma India Limited has 25,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 2.60%
Financial Efficiency
AstraZeneca Pharma India Limited’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.00%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 17.00%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 29.94M
- Profits Per Employee
- 2.47M
- Employee Count
- 760
- Asset Turnover
- 1.14
- Inventory Turnover
- 1.63
Valuation Ratios
The current PE Ratio of AstraZeneca Pharma India Limited is 86.76. AstraZeneca Pharma India Limited’s PEG ratio is -8.06.
- PE Ratio
- 86.76
- PS Ratio
- 5.93
- PB Ratio
- 17.55
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -8.06
Income Statement
In the last 12 months, AstraZeneca Pharma India Limited had revenue of 22.76B and earned 1.88B in profits. Earnings per share was 75.01.
- Revenue
- 22.76B
- Gross Profit
- 6.02B
- Operating Income
- 2.33B
- Pretax Income
- 2.52B
- Net Income
- 1.88B
- EBITDA
- 2.85B
- Earnings Per Share (EPS)
- 75.01
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
AstraZeneca Pharma India Limited pays an annual dividend of INR 32.00, resulting in a dividend yield of 0.58%
- Dividend Per Share
- INR 32.00
- Dividend Yield
- 0.58%
- Payout Ratio
- 40.17%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.15%
Stock Price Statistics
- Beta
- 0.67
- 52-Week Price Change
- -32.48%
- 50-Day Moving Average
- 6316.54
- 200-Day Moving Average
- 7759.93
- Relative Strength Index (RSI)
- 45.79
- Average Volume (3m)
- 545
Important Dates
AstraZeneca Pharma India Limited upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 14, 2027
- Ex-Dividend Date
- Jul 18, 2025
Financial Position
AstraZeneca Pharma India Limited as a current ratio of 1.77, with Debt / Equity ratio of 12.68%
- Current Ratio
- 1.77
- Quick Ratio
- 0.73
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.18
- Interest Coverage Ratio
- 51.99
Taxes
In the past 12 months, AstraZeneca Pharma India Limited has paid 646.80M in taxes.
- Income Tax
- 646.80M
- Effective Tax Rate
- 0.26
Enterprise Valuation
AstraZeneca Pharma India Limited EV to EBITDA ratio is 57.06, with an EV/FCF ratio of 0.00.
- EV to Sales
- 5.74
- EV to EBITDA
- 57.06
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
AstraZeneca Pharma India Limited has INR 5.87B in cash and marketable securities with INR 962.10M in debt, giving a net cash position of INR 4.90B billion.
- Cash & Marketable Securities
- INR 5.87B
- Total Debt
- INR 962.10M
- Net Cash
- INR 4.90B
- Net Cash Per Share
- INR 196.15
- Tangible Book Value Per Share
- INR 351.54
Margins
Gross margin is 30.16%, with operating margin of 8.85%, and net profit margin of 6.83%.
- Gross Margin
- 30.16%
- Operating Margin
- 8.85%
- Pretax Margin
- 9.37%
- Net Profit Margin
- 6.83%
- EBITDA Margin
- 10.06%
- EBIT Margin
- 9.30%
Analyst Forecast
The average price target for AstraZeneca Pharma India Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 29.70%
- EPS Growth Forecast
- -10.76%
Scores
- Smart Score
- ―
- AI Score
- 49

